Literature DB >> 16837009

A dimeric kinase assembly underlying autophosphorylation in the p21 activated kinases.

Michelle Pirruccello1, Holger Sondermann, Jeffrey G Pelton, Patricia Pellicena, André Hoelz, Jonathan Chernoff, David E Wemmer, John Kuriyan.   

Abstract

The p21-activated kinases (PAKs) are serine/threonine kinases that are involved in a wide variety of cellular functions including cytoskeletal motility, apoptosis, and cell cycle regulation. PAKs are inactivated by blockage of the active site of the kinase domain by an N-terminal regulatory domain. GTP-bound forms of Cdc42 and Rac bind to the regulatory domain and displace it, thereby allowing phosphorylation of the kinase domain and maximal activation. A key step in the activation process is the phosphorylation of the activation loop of one PAK kinase domain by another, but little is known about the underlying recognition events that make this phosphorylation specific. We show that the phosphorylated kinase domain of PAK2 dimerizes in solution and that this association is prevented by addition of a substrate peptide. We have identified a crystallographic dimer in a previously determined crystal structure of activated PAK1 in which two kinase domains are arranged face to face and interact through a surface on the large lobe of the kinase domain that is exposed upon release of the auto-inhibitory domain. The crystallographic dimer is suggestive of an engagement that mediates trans-autophosphorylation. Mutations at the predicted dimerization interface block dimerization and reduce the rate of autophosphorylation, supporting the role of this interface in PAK activation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16837009     DOI: 10.1016/j.jmb.2006.06.017

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  46 in total

1.  Autophosphorylation within the Atg1 activation loop is required for both kinase activity and the induction of autophagy in Saccharomyces cerevisiae.

Authors:  Yuh-Ying Yeh; Kristie Wrasman; Paul K Herman
Journal:  Genetics       Date:  2010-05-03       Impact factor: 4.562

Review 2.  PAK1 as a therapeutic target.

Authors:  Julia V Kichina; Anna Goc; Belal Al-Husein; Payaningal R Somanath; Eugene S Kandel
Journal:  Expert Opin Ther Targets       Date:  2010-07       Impact factor: 6.902

3.  Identification of phosphorylation sites in betaPIX and PAK1.

Authors:  Mark W Mayhew; Erin D Jeffery; Nicholas E Sherman; Kristina Nelson; Joy M Polefrone; Stephen J Pratt; Jeffrey Shabanowitz; J Thomas Parsons; Jay W Fox; Donald F Hunt; Alan F Horwitz
Journal:  J Cell Sci       Date:  2007-11-15       Impact factor: 5.285

4.  Analysis of conformational changes during activation of protein kinase Pak2 by amide hydrogen/deuterium exchange.

Authors:  Yuan-Hao Hsu; David A Johnson; Jolinda A Traugh
Journal:  J Biol Chem       Date:  2008-11-04       Impact factor: 5.157

5.  Auto-activation mechanism of the Mycobacterium tuberculosis PknB receptor Ser/Thr kinase.

Authors:  Carl Mieczkowski; Anthony T Iavarone; Tom Alber
Journal:  EMBO J       Date:  2008-11-13       Impact factor: 11.598

Review 6.  P21 activated kinases: structure, regulation, and functions.

Authors:  Chetan K Rane; Audrey Minden
Journal:  Small GTPases       Date:  2014-03-21

7.  Dissecting activation of the PAK1 kinase at protrusions in living cells.

Authors:  Maria Carla Parrini; Jacques Camonis; Michiyuki Matsuda; Jean de Gunzburg
Journal:  J Biol Chem       Date:  2009-07-01       Impact factor: 5.157

8.  Use of a decoy peptide to purify p21 activated kinase-1 in cardiac muscle and identification of ceramide-related activation.

Authors:  Yunbo Ke; R John Solaro
Journal:  Biologics       Date:  2008-12

Review 9.  PAK signaling in oncogenesis.

Authors:  P R Molli; D Q Li; B W Murray; S K Rayala; R Kumar
Journal:  Oncogene       Date:  2009-05-25       Impact factor: 9.867

10.  Interaction with LC8 is required for Pak1 nuclear import and is indispensable for zebrafish development.

Authors:  Christine M Lightcap; Gabor Kari; Luis E Arias-Romero; Jonathan Chernoff; Ulrich Rodeck; John C Williams
Journal:  PLoS One       Date:  2009-06-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.